Skip to content

ELEKTA

Active
Public limited companyfounded 199729 yrs activeBelgicastraat 11, 1930 Zaventem, BelgiumKBO/BCE: BE 0460.510.369
Summary

ELEKTA has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2.7m and a net result of €753,993. Equity is shrinking by ~4.1% per year across the filed fiscal years. Its solvency ranks better than 19% of 204 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.5% (low).

Risk analysisWatch ReportCompare
ELEKTAActiveChecked score 80/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
Size
€13.9mturnover 2026
Staff
12.2 FTE
Equity
€2.7m
Profit
€753,993
Financial health
80 Excellent Checked score 2026
Bankruptcy chance 12 m
0.5%
Structure
Parent
Elekta AB · 99.6%
Board
3 members
Auditor: Ernst et Young Reviseurs d'EntreprisesAccounts 68 d early
Why 80- Liquidity: current ratio 1.93, cash €2,840- Equity €2.7m (21.0% of total assets)- 1 of the last 3 late+ Founded in 1997Show the evidence

Checked score

Score 2026
80 / 100
Excellent
Probability in this band: under 0.55%
Better than 38% of its sector peers (NACE 46, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2025
Average
Solvency 46-6
equity 21.0% of total assets
Liquidity 25-41
short-term debt 49.6% · cash 0.0%
Profitability 70=
return on assets 5.8%
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,367 companies)
Last 15 months 08-2025: 0.9% 09-2025: 0.8%▼ -14.8% vs 08-2025 10-2025: 0.8%▲ +2.6% vs 09-2025 11-2025: 0.9%▲ +13.5% vs 10-2025 12-2025: 1.3%▲ +49.0% vs 11-2025highest value 01-2026: 0.4%▼ -73.1% vs 12-2025 02-2026: 0.4%● 0.0% vs 01-2026 03-2026: 0.4%● 0.0% vs 02-2026 04-2026: 0.4%● 0.0% vs 03-2026 05-2026: 0.4%● 0.0% vs 04-2026 06-2026: 0.3%▼ -3.7% vs 05-2026 07-2026: 0.3%▲ +1.5% vs 06-2026 08-2026: 0.3%▼ -2.6% vs 07-2026lowest value 09-2026: 0.3%▲ +3.3% vs 08-2026 10-2026: 0.5%▲ +58.2% vs 09-2026
  • Liquidity: current ratio 1.93, cash €2,840 raises the probability
  • Equity €2.7m (21.0% of total assets) raises the probability
  • Founded in 1997 lowers the probability for this profile
  • 1 of the last 3 late raises the probability
Credit up to €210,000 at 30 days acceptable
Liquidity ample (current ratio 1.93 against 2.58 in 2025; short-term debt: 49.6% and cash: 0% of total assets), but 79% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, small). Better than this share of them on solvency 24%, liquidity 23%, profitability 60%, growth against the median 46%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 1.93, cash €2,840
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Equity €2.7m (21.0% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Founded in 1997
In the bankruptcy model this factor lowers the probability for this profile.
KBO
raises risk · 1 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 204 sector peers (2026).
NBB · sector comparison
Position among 204 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 30-04-2026 was due by 30-11-2026 and was filed on 23-09-2026, 68 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
68 d early
2025
9 d late
2024
304 d late
2023
252 d late
2022
253 d late
2021
93 d late
2020
21 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 123 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-04-2027 and is due by 30-11-2027. Nothing is late today. Usually files around 8 August (4 of the last 5 filed years within 243 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today30-04-2027 close30-11-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2026 · full…
  2. Resignation: Jean Emmanuel Picard (director)Appointment: Jan Gerrit VAN DE…
  3. Reappointments: Michel Guerchaft (director) and EY…Permanent representative: Emilie Van Callemont…

Key points

  • Caution: Among the weakest 20% on solvencysector median 46.1% · 204 companies 21.0% View
  • Positive: 8 profitable years in a rowprofit 2026: €753,993 8 years View
  • Caution: Equity fell in 2026from €4.0m to €2.7m ▼ 31.2% View
  • New directorlatest change 30-04-2026 · 3 in office 1 joined View
  • Known shareholderslargest: Elekta AB 99.6% 100% View

By topic

Financials

Fiscal year
2026
Turnover
€13.9m
Profit
€753,993
Solvency
21.0%
Turnover▲ 13.5%
Net result
20192026
Go to Financials

Board & ownership

Board
3 members
Largest shareholder
Elekta AB · 99.6%
Known shareholders
100%
Auditor
Ernst et Young Reviseurs…
Go to Board & ownership

Timeline

Events
36
Since
2007
Next accounts
by 30-11-2027
  1. 23-09-2026Annual accounts filed
  2. 23-06-2026Resignation: Jean Emmanuel Picard (director)
  3. 09-02-2026Reappointments: Michel Guerchaft (director) and EY BEDRIJFSREVISOREN…
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
17-04-1997
Year ends
30-04
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
1
Purpose
De vennootschap heeft tot doel, zowel in Belgie als in het buitenland, de consulting, de…
Go to Articles of association

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure